“DENDRON-02: Efficacy and Safety of Combined Dendritic Cell Vaccine CaTeVac Immunotherapy and Standard Chemotherapy in Patients With CNS Glial Tumors. First Results”. Voprosy onkologii 72, no. 2 (May 8, 2026): OF-2504. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/2-26-DENDRON-02.